Related Experiment Video
Updated: Jul 18, 2026

Visualisation and Quantification of Intracellular Interactions of Neisseria meningitidis and Human α-actinin by Confocal Imaging
Published on: October 24, 2010
A surveillance network for meningococcal disease in Europe
Caroline L Trotter1, Manosree Chandra, Rosa Cano
1Immunization Department, Health Protection Agency Centre for Infections, London, UK.
Abstract:
Between 1999 and 2004, the European Union Invasive Bacterial Infections Surveillance Network (EU-IBIS) received c. 50,000 reports of meningococcal disease from 27 participating countries. Analysis has demonstrated a major decline in the incidence of invasive disease in those countries that have introduced routine vaccination against serogroup C infection. The establishment of rapid reporting of W135 and B2a/B2b strains has been able to provide early reassurance that these strains are not emerging as major public health problems in Europe. Between September 2001 and February 2005, the EU-MenNet project offered further opportunities for enhancing this data resource. Collaborative projects included: improving the EU-IBIS website; reviewing case ascertainment in Europe; reviewing cost-effectiveness studies for meningococcal serogroup C conjugate (MCC) vaccination; international comparisons of MCC vaccine efficacy; and mathematical modelling studies. In addition, linking of data from the European Meningococcal Multi-locus Sequence Type Centre to epidemiological data was performed. Particular clonal complexes were found to be preferentially associated with certain serogroups. Case fatality was also found to vary with clonal complex, suggesting that genotype can be a marker for hypervirulence. The importance of close collaboration between networks of epidemiologists, microbiologists, and the wider scientific and public health community is demonstrated.
Insights
Routine vaccination against meningococcal serogroup C infection significantly reduced invasive disease incidence in Europe. Surveillance data also confirmed W135 and B2a/B2b strains did not emerge as major public health threats.
Area of Science:
- Epidemiology
- Microbiology
- Public Health
Background:
- The European Union Invasive Bacterial Infections Surveillance Network (EU-IBIS) collected approximately 50,000 reports of meningococcal disease between 1999 and 2004.
- Routine vaccination against serogroup C meningococcal infection has been implemented in several European countries.
Purpose of the Study:
- To analyze trends in invasive meningococcal disease incidence across Europe.
- To monitor the emergence of specific meningococcal strains (W135, B2a/B2b).
- To enhance data resources and collaborative projects through the EU-MenNet initiative.
Main Methods:
- Analysis of surveillance data from the EU-IBIS network.
- Rapid reporting systems for emerging meningococcal strains.
- Collaborative projects including website improvement, case ascertainment review, cost-effectiveness studies, vaccine efficacy comparisons, and mathematical modeling.
- Linking epidemiological data with multi-locus sequence typing data.
Main Results:
- A significant decline in invasive meningococcal disease incidence was observed in countries with routine serogroup C conjugate (MCC) vaccination.
- Emerging W135 and B2a/B2b strains were monitored, with no indication of them becoming major public health issues.
- Specific clonal complexes were associated with particular serogroups, and case fatality varied with clonal complex, suggesting genotype may indicate hypervirulence.
Conclusions:
- Routine MCC vaccination is effective in reducing invasive meningococcal disease.
- Robust surveillance systems are crucial for monitoring bacterial infections and emerging strains.
- Collaboration among epidemiologists, microbiologists, and public health professionals is vital for effective disease control.
Related Concept Videos
Bacterial Meningitis
Bacterial Meningitis I: Introduction
Principles of Disease Surveillance
Cryptococcal Meningitis
Viral Meningitis
Bacterial Meningitis II: Pathophysiology
